New Jersey A5534 revises telehealth and telemedicine requirements for adult prescription of Schedule II drugs for ADHD treatment.
New Jersey A5534 revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder. The bill mandates an initial in-person examination before prescribing such drugs via telemedicine or telehealth. It allows subsequent follow-up visits every six months to be conducted either in-person or via telemedicine or telehealth. The bill also requires health care providers to review the patient's medical history and records before initiating contact.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.